Your SlideShare is downloading. ×
DENGUE FEVER
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

DENGUE FEVER

41,451

Published on

Published in: Health & Medicine
3 Comments
33 Likes
Statistics
Notes
No Downloads
Views
Total Views
41,451
On Slideshare
0
From Embeds
0
Number of Embeds
13
Actions
Shares
0
Downloads
0
Comments
3
Likes
33
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. DENGUE FEVER Prof. D. S. Akram Dr. Saba Ahmed Peads Unit 1 CHK, DUHS
  • 2. INTRODUCTION
    • Dengue fever (DF) and Dengue
    • hemorrhagic fever (DHF) rank high
    • among infectious diseases and are
    • considered to be most important of
    • arthropod born viral diseases
  • 3. MOSQUITO VECTOR
    • DF is caused by mosquito of genus Aedes ,most important is A.aegypti which is a day biting mosquito, rests indoors and can breed in small collection of water.
    • Rainy season increase risk of DF as it increases larval population ,also ambient temperature and humidity favor viral propagation
  • 4. MOSQUITO VECTOR
    • Improper arrangements for disposal of
    • solid wastes and water which are
    • mainly consequences of unplanned
    • urbanization play a major role in
    • propagation of mosquitoes
  • 5. DENGUE VIRUS
    • It is an RNA virus belonging to Flaviviridae group
    • Consists of 4 serotypes,DEN-1—DEN-4
    • All are capable of causing disease in humans
    • Recent trends show increase prevalence of DEN-3serotype
  • 6. EPIDEMIOLOGY
    • DHFwas first recognized in Manila in 1953.Major epidemics since then in India,China,Thailand ,Malaysia. In 1998 major pandemic in 56 countries Recent epidemics in Bangladesh and India.
    • In Karachi one outbreak was reported in 1994 and two occurred recently in 2005 and 2006
  • 7. EPIDEMIOLIGICAL PATTERN OF DENGUE FEVER
  • 8. CLINICAL FEATURES
    • Dengue infection ranges from DF to more
    • severe Dengue hemorrhagic fever (DHF)
    • Or Dengue shock syndrome (DSS).
    • DF usually occurs after primary infection
    • whereas DHF and DSS follow secondary
    • Infections.
  • 9. WHO Case Definition: Dengue Fever
    • Acute fever with 2 or more
    • Retro-orbital pain
    • Myalgia/arthralgia
    • Maculopapular rash
    • Hemorrhagic manifestation
    • Supportive serology
  • 10. WHO Case Definition Dengue Hemorrhagic Fever
    • Any patient with following 4 criteria
    • Acute onset of fever for 2-7 days
    • Hemorrhagic manifestation,atleast one
    • (+ve tourniquet test,petaechae , echymosis,mucosal or GI bleed)
    • Thrombocytopenia(<100x10 9 L)
    • Evidence of plasma leak (hematocrit> 20%,pleural effusion, low serum albumin)
  • 11. WHO Case Definition Dengue Shock Syndrome
    • All criteria of DHF plus evidence of circulatory failure like
    • Rapid and weak pulse
    • Narrow pulse pressure(20mm Hg)
    • Hypotension
  • 12. WHO Grading of DHF
    • This is especially useful in epidemics
    • GRADE I: No shock only +ve tourniquet
    • GRADE II: No shock, spontaneous bleeding
    • GRADE III:Shock
    • GRADE IV: Profound shock
  • 13. CLINCAL PRESENTATION
  • 14. Hemorrhagic Manifestations
  • 15. SKIN RASHES IN DENGUE FEVER
  • 16. Difference between children and adults
    • Children: primary infections in 2 age peaks, infancy and 3-5 years
    • Common presentation: fever ,rash, coryza, hepatosplenomegaly, abdominal pain, rapid progression to shock and encephalopathy.
    • Adults : secondary infections
    • Common presentation:headache,arthralgia
    • myalgia, bleeding
  • 17. Dengue Cases in 1980
    • In 1980, in a study done by Prof.D.S.Akram on virus encephalitis. 30 cases of encephalitis were investigated by Haemmagglutinition Inhibition (HI) for flaviviruses. 8 out of 30 had positive HI for DEN-2.
    • Therefore DF was present in our population even in 1980’s.
  • 18. Dengue Virus Infection Karachi (1994)
    • A study conducted in Karachi by Prof.D.S.Akram in 1994 comprising of 122 children found 26% children with undifferentiated fever to be sero-positive for Dengue fever, they also had higher incidence of hepato-splenomegaly and anemia.
    • Indian j pediatr 1998, 65: 735-740
  • 19. IgM – ELISA ON Serum specimens from Karachi, Pakistan, 1994
    • Clinical Diagnosis and
    • Serum Specimen No. of Specimens
    • Positive with Antigen of
    • ------------------------------------------ Total D1 D2 WN JE
    • Undifferentiated fever
    • Single Serum 92 5 8 5 0
    • Paired Serum 25 3 6 1 0
    • DHF Single Serum 5 4 4 0 0
    • Total 122 12 18 6 0
  • 20. Clinical Characteristics of patients with and without Anti-dengue IgM
    • Variables Anti-Dengue IgM (+) Anti-dengue IgM (-)
    • Age (years) 3.7 yrs 4.9
    • Sex M: F 1.1: 1 2.3: 1
    • Fever duration 2.8 days 3.8 days
    • Degree 99°-102° F 99°-102° F
    • Type Cont / Intermittent Cont / Intermittent
    • Cough 16.6% 35.3%
    • weakness 16.6% 10.6%
    • Anemia 66.6% 30.9%
    • Hepatomology 33.3% 12.3%
    • Splenomegaly 16.6% 1.7%
  • 21. Recent epidemic of Dengue fever
    • A surveillance study was done recently in Civil and Lyari hospitals during July –October 2005 .
    • 350 patients with fever of less than 7 days were screened for DF according to WHO criteria.22 serum samples were tested for anti-dengue IgM by MAC-ELISA method.
    • 4 turned out to be positive and 11 were indeterminate
  • 22. Dengue fever 2006
    • Recent survey October-November2006 of 35 serologically proven cases of DF in children showed following clinical features:
    • Fever,abdominal pain,rash,vomittingbleeding and bone pains
  • 23.
    • These studies point towards the fact that Dengue infection in our population has increased in last two decades and periodic epidemics like in 1994, 2005, 2006 are seen especially after heavy rainfall.
  • 24.
    • All patients don’t need admission
    • WHAT TO DO?
    • In a child with undifferentiated fever>38 o c and <7 days
    • acute serum collected
    • Platelets and hematocrit checked
    • Tourniquet test done
    Outpatient management of DF
  • 25. Outpatient management of DF(cont)
    • Child should be given
    • ORS
    • Paracetamol for fever
    • Counselling done to watch for:
    • restlesness,lethergy,cold extremeties,low
    • volume pulse,oliguria
  • 26. Outpatient management of DF(cont)
    • Daily monitoring for upto 2 days after defervescence of fever of following:
    • Hematocrit
    • Platelets
    • Evidence of bleeding:
    • epistaxis,hematemesis,gum bleed,malena etc
  • 27. Indications of hospitalization
    • Patient has signs of dehydration:
    • tachycardia,capillary refill>2 secs,cold extremeties,oliguria
    • Increase in hematocrit>20%
    • Narrowing of pulsepressure<20mmHg
    • Bleeding
    • Thrombocytopenia
  • 28. Volume replacement in DHF with >20%hematocrit
    • Assume 5% isotonic dehydration
    • PLAN OF REHYDRATION
    • 1/5 dextrose saline or Ringolactate should be used
    • Amount of fluid=
    • maintenance+5%deficit+daily output
  • 29. TREATEMENT DURING INDONESIAN EPIDEMIC
  • 30. CHILD WITH DENGUE SHOCK SYNDROME
  • 31. Volume replacement in DHF with >20%hematocrit (cont)
    • If child shows improvement
    • maintenance fluid continued for 24-48 hours
    • Increase in monitoring intervals
  • 32. Management of Thrombocytopenia
    • Platelets should be given in following condition:
    • Platelet count<20,000/mm
    • Thrombocytopenia with active bleeding
    • Over use of platelets should be avoided as it is not necessary and causes shortage of stores in blood banks
  • 33. Criteria for discharging inpatients
    • Absence of fever for at least 24 hours
    • Good urine output
    • Stable hematocrit
    • Passing of at least 2 days after recovery from shock
    • Platelet count>50,000/mm
  • 34. PREVENTION
    • Vaccination:
    • Live attenuated tetra-valent vaccine
    • against all sero types is under trial.
    • Recombinant vaccines are also being tried
  • 35. PREVENTION
    • Many strategies like
    • Environmental control :
    • Reducing vector breeding site, solid waste management, proper water drainage, personal protection and public education
    • Chemical control:
    • Space spraying of insecticide
    • Regular monitoring of mosquito resistance pattern
  • 36. Conclusion
    • In light of these findings it can be recommended:
    • Children having no focus of infection and with negative investigations for malaria and UTI should be investigated Dengue fever
  • 37. Conclusion……….. Cont.
    • In surveillance studies for children under 2 years of age WHO surveillance should also be modified to include all children with fever < 7 days without any focus of infection
  • 38. Surveillance of Dengue fever:
    • Formulation of surveillance programmes in endemic areas require monitoring of suspected cases ,case reporting, epidemiological and entomological investigation
  • 39. Thank You Prof. D. S. Akram Dr Saba Ahmed Peads Unit 1 CHK, DUHS

×